Though Dr. Brian Walitt has been collaborating with the NINDS as a clinician with NINR since the launch of the NIH Director’s Initiative study Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in 2016, he officially joined the NINDS Clinical Neurosciences Program as a Staff Clinician in 2021 heading the Interoceptive Disorders Unit.
Dr. Walitt received his Medical Doctorate from the State University of New York Heath Science Center at Syracuse and subsequently completed his residency and a Masters in Public Health at George Washington University and his rheumatology fellowship at MedStar Washington Hospital Center. Upon completion of his training, he practiced for over a decade at the Washington Hospital Center, serving as the Research Director and Associate Chairman of Rheumatology. He was recognized as an Associate Professor at Georgetown University for his fibromyalgia and rheumatoid arthritis research work. Since arriving at NIH in 2013, he has served as the Medical Officer of NINR, NIDCR, and the acting Clinical Director of NCCIH. His research protocols focus on deeply phenotyping persons with disorders characterized by aversive symptoms that develop after exposures, such as infection. Currently, he is working with patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Gulf War Illness (GWI), and Post-Acute Sequelae of SARS-CoV-2 infection (PASC).